Anaphase-specific activation of the MEN in the absence of TEM1. (A,B) Wild-type (A2747) and lte1Δ kin4Δ (A26379) cells containing 3HA-Cdc14 and 3MYC-Dbf2 fusion proteins were arrested in G1 with α-factor pheromone (5 μg/mL) in YEP medium containing glucose (YEPD). When the arrest was complete (after 150 min), cells were released into pheromone-free YEPD medium. After 80 min, α-factor pheromone (10 μg/mL) was re-added to prevent entry into the subsequent cell cycle. The percentage of cells with metaphase spindles (closed squares; A), anaphase spindles (closed circles; A), and 3HA-Cdc14 released from the nucleolus (open circles; A), and the amount of Dbf2-associated kinase activity (Dbf2 kinase; B) and immunoprecipitated 3MYC-Dbf2 (Dbf2 IP; B) were determined at the indicated times. (C) Wild-type (A2747) and tem1Δ CDC15-UP (A22670) cells containing 3HA-Cdc14 and 3MYC-Dbf2 fusion proteins were spotted on YEP plates containing raffinose and galactose (YEPRG) at 30°C. Approximately 3 × 104 cells were deposited in the first spot, and each subsequent spot is a 10-fold serial dilution. The picture shown depicts 3 d of growth. (D,E) Wild-type (A2747) and tem1Δ CDC15-UP (A22670) cells containing 3HA-Cdc14 and 3MYC-Dbf2 fusion proteins were arrested in G1 with α-factor pheromone (5 μg/mL) in YEPRG medium. When the arrest was complete (after 2 h 50 min), cells were released into pheromone-free YEPRG medium. After 60 min, α-factor pheromone (10 μg/mL) was added to prevent entry into the subsequent cell cycle. The percentage of cells with metaphase spindles (closed squares; D), anaphase spindles (closed circles; D), and 3HA-Cdc14 released from the nucleolus (open circles; D), and the amount of Dbf2-associated kinase activity (Dbf2 kinase; E) and immunoprecipitated 3MYC-Dbf2 (Dbf2 IP; E) were determined at the indicated times. (F) The amount of Dbf2-associated kinase activity and immunoprecipitated 3MYC-Dbf2 from E was determined by quantitative autoradiography and quantitative Western blot, respectively. Shown is the specific Dbf2-associated kinase activity.